help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polanczyk, M.
Right arrow Articles by Teuscher, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polanczyk, M.
Right arrow Articles by Teuscher, C.
(American Journal of Pathology. 2004;164:1915-1924.)
© 2004 American Society for Investigative Pathology

Estrogen Receptor-1 (Esr1) and -2 (Esr2) Regulate the Severity of Clinical Experimental Allergic Encephalomyelitis in Male Mice

Magdalena Polanczyk*, Srikanth Yellayi{dagger}, Alex Zamora*, Sandhya Subramanian*, Micah Tovey*, Arthur A. Vandenbark*, Halina Offner*, James F. Zachary{ddagger}, Parley D. Fillmore{ddagger}, Elizabeth P. Blankenhorn§, Jan-Åke Gustafsson and Cory Teuscher||

From the Department of Neurology,*Oregon Health and Science University, Portland, Oregon; the Department of Pathobiology,{dagger}University of Pennsylvania, Philadelphia, Pennsylvania; the Department of Pathobiology,{ddagger}University of Illinois at Urbana-Champaign, Urbana, Illinois; the Department of Microbiology and Immunology,§Drexel University College of Medicine, Philadelphia, Pennsylvania; the Department of Medicine,||University of Vermont, Burlington, Vermont; and the Department of Medical Nutrition,Karolinska Institute, Stockholm, Sweden

Estrogens and estrogen-receptor signaling function in establishing and regulating the female immune system and it is becoming increasingly evident that they may play a similar role in males. We report that B10.PL/SnJ male mice with a disrupted estrogen receptor-1 ({alpha}) gene (Esr1–/–) develop less severe clinical experimental allergic encephalomyelitis (EAE) compared to either Esr1+/– or wild-type (Esr1+/+) controls when immunized with myelin basic protein peptide Ac1-11 (MBPAc1-11). In contrast, the disease course in B10.PL/SnJ male mice with a disrupted estrogen receptor-2 (ß) gene (Esr2–/–) does not differ from that of wild-type (Esr2+/+) mice. However, Esr2+/– mice do develop more severe clinical disease with an earlier onset indicating that heterosis at Esr2 plays a significant role in regulating EAE in males. No significant differences in central nervous system histopathology or MBPAc1-11-specific T-cell responses as assessed by proliferation and interleukin-2 production were observed as a function of either Esr1 or Esr2 genotype. An analysis of cytokine/chemokine secretion by MBPAc1-11-specific T cells revealed unique Esr1 and Esr2 genotype-dependent regulation. Interferon-{gamma} secretion was found to be negatively regulated by Esr1 whereas interleukin-6 and tumor necrosis factor-{alpha} secretion exhibited classical Esr2 gene dose responses. Interestingly, MCP-1 displayed distinctively unique patterns of genotype-dependent regulation by Esr1 and Esr2. The contribution of the hematopoietic and nonhematopoietic cellular compartments associated with the heterotic effect at Esr2 in regulating the severity of clinical EAE was identified using reciprocal hematopoietic radiation bone marrow chimeras generated between male wild-type and Esr2+/– mice. Wild-type -> Esr2+/– mice exhibited EAE equivalent in severity to that seen in Esr2+/– -> Esr2+/– control constructs; both of which were more severe than the clinical signs observed in Esr2+/– -> wild-type and wild-type -> wild-type mice. These results indicate that the heterotic effect at Esr2 is a function of the nonhematopoietic compartment.





This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
R. Noubade, R. del Rio, B. McElvany, J. F. Zachary, J. M. Millward, D. D. Wagner, H. Offner, E. P. Blankenhorn, and C. Teuscher
Von-Willebrand Factor Influences Blood Brain Barrier Permeability and Brain Inflammation in Experimental Allergic Encephalomyelitis
Am. J. Pathol., September 1, 2008; 173(3): 892 - 900.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Teuscher, M. Subramanian, R. Noubade, J. F. Gao, H. Offner, J. F. Zachary, and E. P. Blankenhorn
Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS
PNAS, June 12, 2007; 104(24): 10146 - 10151.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y.-C. Hsieh, H.-P. Yu, M. Frink, T. Suzuki, M. A. Choudhry, M. G. Schwacha, and I. H. Chaudry
G Protein-Coupled Receptor 30-Dependent Protein Kinase A Pathway Is Critical in Nongenomic Effects of Estrogen in Attenuating Liver Injury after Trauma-Hemorrhage
Am. J. Pathol., April 1, 2007; 170(4): 1210 - 1218.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
H. H. van den Broek, J. G. Damoiseaux, M. H De Baets, and R. M. Hupperts
The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review
Multiple Sclerosis, June 1, 2005; 11(3): 349 - 359.
[Abstract] [PDF]


Home page
J EndocrinolHome page
M M. Elloso, K. Phiel, R. A Henderson, H. A Harris, and S. J Adelman
Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands
J. Endocrinol., May 1, 2005; 185(2): 243 - 252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.